A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

NCT06727604 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Graves' Disease

Interventions

DRUG: IMVT-1402
DRUG: IMVT-1402
DRUG: Placebo

Sponsor

Immunovant Sciences GmbH